Jeong, Han-Gil;
Cha, Bong Geun;
Kang, Dong-Wan;
Kim, Do Yeon;
Ki, Seul Ki;
Kim, Song I.;
Han, Ju hee;
Yang, Wookjin;
Kim, Chi Kyung;
Kim, Jaeyun;
Lee, Seung-Hoon
Ceria Nanoparticles Synthesized With Aminocaproic Acid for the Treatment of Subarachnoid Hemorrhage
You can manage bookmarks using lists, please log in to your user account for this.
Media type:
E-Article
Title:
Ceria Nanoparticles Synthesized With Aminocaproic Acid for the Treatment of Subarachnoid Hemorrhage
Contributor:
Jeong, Han-Gil;
Cha, Bong Geun;
Kang, Dong-Wan;
Kim, Do Yeon;
Ki, Seul Ki;
Kim, Song I.;
Han, Ju hee;
Yang, Wookjin;
Kim, Chi Kyung;
Kim, Jaeyun;
Lee, Seung-Hoon
Published in:
Stroke, 49 (2018) 12, Seite 3030-3038
Language:
English
DOI:
10.1161/strokeaha.118.022631
ISSN:
0039-2499;
1524-4628
Origination:
Footnote:
Description:
Background and Purpose— Despite early aneurysm repair and aggressive management for complications, subarachnoid hemorrhage (SAH) results in at least 25% mortality rate and 50% persistent neurological deficit. We investigated whether ceria nanoparticles which have potent antioxidative activities can protect against subarachnoid hemorrhage via attenuating fatal brain injuries. Methods— Uniform, 3 nm, water-dispersed ceria nanoparticles were prepared from short sol-gel reaction of cerium (III) ions with aminocaproic acid in aqueous phase. SAH was induced by endovascular perforation of middle cerebral artery of rats. A single dose of ceria nanoparticles (0.5 mg Ce/kg) or saline control was randomly administered intravenously at an hour post-SAH. Neuronal death, macrophage infiltration, SAH grade, and brain edema were evaluated at 72 hours. Mortality and neurological function were assessed for 14 days. Results— The obtained ceria nanoparticles with high Ce 3+ to Ce 4+ ratio demonstrated potent antioxidative, cytoprotective, and anti-inflammatory activities in vitro. In rodent SAH models, the severity of hemorrhage was comparable between the ceria nanoparticles- and saline-treated groups. However, ceria nanoparticles significantly reduced neuronal death, macrophage infiltration, and brain edema after SAH. Ceria nanoparticles successfully improved survival rates (88.2% in the ceria nanoparticles group versus 21.1% in the control group; P <0.001) and neurological outcomes (modified Garcia score: 12.1±0.5 in the ceria nanoparticles group versus 4.4±0.5 in the control group; P <0.001) of the animals with SAH. Conclusions— Ceria nanoparticles, totally synthesized in aqueous phase using aminocaproic acid, demonstrated promising results against SAH via potent antioxidative, neuroprotective and anti-inflammatory activities. Given the obvious limitations of current therapies for SAH, ceria nanoparticles can be a potential therapeutic agent which might result in a paradigm shift in SAH treatment.